Latest news and articles about Realcan Pharmaceutical
Total: 1 articles found
Chinese regulators are penalizing medical device companies that provide 'free' equipment to hospitals in exchange for exclusive consumable contracts. This crackdown targets the 'lock-in' business model of the In Vitro Diagnostics industry to prevent market monopolization and promote fair competition under revised anti-bribery laws.